natgillin/translations-raw huggingface dataset:
Benzoic acid has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 3, veterinary hygiene biocidal products, and product-type 4, food and feed area disinfectants, as defined in Annex V to that Directive, which correspond respectively to product-types 3 and 4 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 11(2) Direktive 98/8/ES je bila opravljena presoja benzojske kisline glede uporabe v 3. vrsti proizvodov (veterinarskohigienski biocidni proizvodi) in 4. vrsti proizvodov (dezinfekcijska sredstva za območja s hrano in krmo), kot sta opredeljeni v Prilogi V k navedeni direktivi, ki ustrezata 3. in 4. vrsti proizvodov, kot sta opredeljeni v Prilogi V k Uredbi (EU) št. 528/2012.
Germany was designated as Rapporteur Member State and submitted the competent authority reports, together with recommendations, to the Commission on 3 February 2011 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Nemčija, ki je bila imenovana za državo članico poročevalko, je 3. februarja 2011 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročili pristojnega organa in priporočili.
The competent authority reports were reviewed by the Member States and the Commission.
Države članice in Komisija so pregledale poročili pristojnega organa.
In accordance with Article 15(4) of Regulation (EC) No 1451/2007, the findings of the review were incorporated, within the Standing Committee on Biocidal Products on 27 September 2013, in two assessment reports.
V skladu s členom 15(4) Uredbe (ES) št. 1451/2007 so bile 27. septembra 2013 ugotovitve pregleda v Stalnem odboru za biocidne pripravke vključene v poročili o oceni.
It appears from those reports that biocidal products used for product-types 3 and 4 and containing benzoic acid may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Iz navedenih poročil je razvidno, da je za biocidne proizvode, ki se uporabljajo kot proizvodi v 3. in 4. vrsti proizvodov in vsebujejo benzojsko kislino, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to approve benzoic acid for use in biocidal products for product-types 3 and 4.
Zato je primerno odobriti benzojsko kislino za uporabo v biocidnih proizvodih 3. in 4. vrste proizvodov.
Since the evaluations did not address nanomaterials, the approvals should not cover such materials pursuant to Article 4(4) of Regulation (EU) No 528/2012.
Ker presoje niso obravnavale nanomaterialov, odobritve v skladu s členom 4(4) Uredbe (EU) št. 528/2012 ne bi smele zajemati takšnih materialov.
For the use in product-type 4, the evaluation did not adress the incorporation of biocidal products containing benzoic acid in materials and articles intended to come into contact directly or indirectly with food within the meaning of Article 1(1) of Regulation (EC) No 1935/2004 of the European Parliament and of the Council [4].
Glede uporabe v 4. vrsti proizvodov v presoji ni bila obravnavana vključitev biocidnih proizvodov, ki vsebujejo benzojsko kislino v materialih in izdelkih, namenjenih za neposreden ali posreden stik z živili v smislu člena 1(1) Uredbe Evropskega parlamenta in Sveta (ES) št. 1935/2004 [4].
Benzoic acid shall be approved as an active substance for use in biocidal products for product-types 3 and 4, subject to the specifications and conditions set out in the Annex.
Benzojska kislina se odobri kot aktivna snov za uporabo v biocidnih proizvodih 3. in 4. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (OJ L 325, 11.12.2007, p. 3).
Uredba Komisije (ES) št. 1451/2007 z dne 4. Decembra 2007 o drugi fazi desetletnega delovnega programa iz člena 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta o dajanju biocidnih pripravkov v promet (UL L 325, 11.12.2007, str. 3).
Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (OJ L 123, 24.4.1998, p. 1).
Direktiva 98/8/ES Evropskega parlamenta in Sveta z dne 16. Februarja 1998 o dajanju biocidnih pripravkov v promet (UL L 123, 24.4.1998, str. 1).
Regulation (EC) No 1935/2004 of the European Parliament and of the Council of 27 October 2004 on materials and articles intended to come into contact with food and repealing Directives 80/590/EEC and 89/109/EEC (OJ L 338, 13.11.2004, p. 4).
Uredba Evropskega parlamenta in Sveta (ES) št. 1935/2004 z dne 27. oktobra 2004 o materialih in izdelkih, namenjenih za stik z živili, in o razveljavitvi direktiv 80/590/EGS in 89/109/EGS (UL L 338, 13.11.2004, str. 4).
IUPAC Name: Benzoic acid
Ime IUPAC: benzojska kislina
EC No: 200-618-2
Št. ES: 200-618-2
CAS No: 65-85-0
Št. CAS: 65-85-0
For industrial or professional users, safe operational procedures and appropriate organizational measures shall be established.
Za industrijske ali poklicne uporabnike se vzpostavijo postopki varnega ravnanja in primerni organizacijski ukrepi.
For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council [3] or Regulation (EC) No 396/2005 of the European Parliament and of the Council [4] shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded.
Za proizvode, ki lahko povzročajo ostanke v živilih ali krmi, se preveri, ali je treba določiti nove ali spremeniti obstoječe mejne vrednosti ostankov (MRL) v skladu z Uredbo (ES) št. 470/2009 Evropskega parlamenta in Sveta [3] ali Uredbo (ES) št. 396/2005 Evropskega parlamenta in Sveta [4], in sprejmejo se vsi ustrezni ukrepi za zmanjšanje tveganja, da se veljavne MRL ne presežejo.
For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 or Regulation (EC) No 396/2005 shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded.
Za proizvode, ki lahko povzročajo ostanke v živilih ali krmi, se preveri, ali je treba določiti nove ali spremeniti obstoječe mejne vrednosti ostankov (MRL) v skladu z Uredbo (ES) št. 470/2009 Evropskega parlamenta in Sveta ali Uredbo (ES) št. 396/2005 Evropskega parlamenta in Sveta, in sprejmejo se vsi ustrezni ukrepi za zmanjšanje tveganja, da se veljavne MRL ne presežejo.
Products containing benzoic acid shall not be incorporated in materials and articles intended to come into contact with food within the meaning of Article 1(1) of Regulation (EC) No 1935/2004, unless the Commission has established specific limits on the migration of benzoic acid into food or it has been established pursuant to that Regulation that such limits are not necessary.
Proizvodi, ki vsebujejo benzojsko kislino, se ne vključijo v materiale in izdelke, namenjene za stik z živili v smislu člena 1(1) Uredbe (ES) št. 1935/2004, razen če je Komisija določila takšne mejne vrednosti ali če je bilo v skladu z navedeno uredbo določeno, da takšne mejne vrednosti niso potrebne.
Commission Implementing Regulation (EU) No 1036/2013
Izvedbena uredba Komisije (EU) št. 1036/2013
approving etofenprox as an existing active substance for use in biocidal products for product-type 18
o odobritvi etofenproksa kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 18. vrste proizvodov
Etofenprox has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 18, insecticides, acaricides and products to control other arthropods, as defined in Annex V to that Directive, which corresponds to product-type 18 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 11(2) Direktive 98/8/ES je bila opravljena presoja etofenproksa glede uporabe v 18. vrsti proizvodov (insekticidi, akaricidi in proizvodi za nadzor drugih členonožcev), kot je opredeljena v Prilogi V k navedeni direktivi, ki ustreza 18. vrsti proizvodov, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
Austria was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 9 August 2011 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Avstrija, ki je bila imenovana za državo članico poročevalko, je 9. avgusta 2011 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
It appears from that report that biocidal products used for product-type 18 and containing etofenprox may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Iz navedenega poročila je razvidno, da je za biocidne proizvode, ki se uporabljajo kot proizvodi v 18. vrsti proizvodov in vsebujejo etofenproks, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It also appears from the reports that the characteristics of etofenprox render it liable to bioaccumulate (B) and toxic (T), in accordance with the criteria laid down in Annex XIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council [4].
Iz poročil je razvidno tudi, da se etofenproks zaradi svojih značilnosti v skladu z merili iz Priloge XIII k Uredbi (ES) št. 1907/2006 Evropskega parlamenta in Sveta [4] lahko kopiči v organizmih (B) in je strupen (T).
The period of approval should be 10 years in consistency with the current practice under Directive 98/8/EC, since the conditions of Article 90(2) of Regulation (EU) No 528/2012 are not met.
Obdobje odobritve bi moralo biti v skladu s trenutno prakso iz Direktive 98/8/ES, tj. 10 let, saj pogoji iz člena 90(2) Uredbe (EU) št. 528/2012 niso izpolnjeni.
However, for the purpose of authorising products in accordance with Article 23 of Regulation (EU) No 528/2012, etofenprox shall be considered as a candidate for substitution pursuant to Article 10(1)(d) of that Regulation.
Vendar bi bilo treba za namene odobritve proizvodov v skladu s členom 23 Uredbe (EU) št. 528/2012 etofenproks obravnavati kot kandidata za nadomestitev v skladu s členom 10(1)(d) navedene uredbe.
It is therefore appropriate to approve etofenprox for use in biocidal products for product-type 18.
Zato je primerno odobriti etofenproks za uporabo v biocidnih proizvodih 18. vrste proizvodov.
Etofenprox shall be approved as an active substance for use in biocidal products for product-type 18, subject to the specifications and conditions set out in the Annex.
Etofenproks se odobri kot aktivna snov za uporabo v biocidnih proizvodih 18. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).
Uredba (ES) št. 1907/2006 Evropskega parlamenta in Sveta z dne 18. decembra 2006 o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH), o ustanovitvi Evropske agencije za kemikalije ter spremembi Direktive 1999/45/ES ter razveljavitvi Uredbe Sveta (EGS) št. 793/93 in Uredbe Komisije (ES) št. 1488/94 ter Direktive Sveta 76/769/EGS in direktiv Komisije 91/155/EGS, 93/67/EGS, 93/105/ES in 2000/21/ES (UL L 396, 30.12.2006, str. 1).
EC No: 407-980-2
Št. ES: 407-980-2
CAS No: 80844-07-1
Št. CAS: 80844-07-1
Etofenprox is considered a candidate for substitution in accordance with article 10(1)(d) of Regulation (EU) No 528/2012.
Etofenproks se šteje kot kandidat za nadomestitev v skladu s členom 10(1)(d) Uredbe (EU) št. 528/2012.
Commission Implementing Regulation (EU) No 1037/2013
Izvedbena uredba Komisije (EU) št. 1037/2013
approving IPBC as an existing active substance for use in biocidal products for product-type 6
o odobritvi IPBC kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 6. vrste proizvodov
IPBC has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 6, in-can preservatives, as defined in Annex V to that Directive, which corresponds to product-type 6 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 11(2) Direktive 98/8/ES je bila opravljena presoja IPBC glede uporabe v 6. vrsti proizvodov, sredstva za konzerviranje v vsebnikih, kot je opredeljena v Prilogi V k navedeni direktivi, ki ustreza 6. vrsti proizvodov, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
Denmark was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 27 June 2011 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Danska, ki je bila imenovana za državo članico poročevalko, je 27. junija 2011 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
It appears from that report that biocidal products used for product-type 6 and containing IPBC may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Iz navedenega poročila je razvidno, da je za biocidne proizvode, ki se uporabljajo kot proizvodi v 6. vrsti proizvodov in vsebujejo IPBC, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It is therefore appropriate to approve IPBC for use in biocidal products for product-type 6.
Zato je primerno odobriti IPBC za uporabo v biocidnih proizvodih 6. vrste proizvodov.
IPBC shall be approved as an active substance for use in biocidal products for product-type 6, subject to the specifications and conditions set out in the Annex.
IPBC se odobri kot aktivna snov za uporabo v biocidnih proizvodih 6. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
EC No: 259-627-5
Št. ES: 259-627-5
Where a treated article has been treated with or intentionally incorporates IPBC, and where necessary due to the possibility of skin contact as well as the release of IPBC under normal conditions of use, the person responsible for placing the treated article on the market shall ensure that the label provides information on the risk of skin sensitisation, as well as the information referred to in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012.
Kadar je bil izdelek obdelan z IPBC ali ga namensko vsebuje in kadar je to potrebno zaradi možnosti stika s kožo ali sprostitve IPBC v normalnih pogojih uporabe, oseba, pristojna za dajanje obdelanega izdelka na trg, zagotovi, da so na nalepki navedene informacije o tveganju za senzibilizacijo kože in informacije iz drugega pododstavka člena 58(3) Uredbe (EU) št. 528/2012.
Commission Implementing Regulation (EU) No 1038/2013
Izvedbena uredba Komisije (EU) št. 1038/2013
approving tebuconazole as an existing active substance for use in biocidal products for product-types 7 and 10
o odobritvi tebukonazola kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 7. in 10. vrste proizvodov
Tebuconazole has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 7, film preservatives, and product-type 10, masonry preservatives, as defined in Annex V to that Directive, which correspond respectively to product-types 7 and 10 as defined in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 11(2) Direktive 98/8/ES je bila opravljena presoja tebukonazola glede uporabe v 7. vrsti proizvodov (sredstva za zaščito (ohranitev) prevlek) in 10. vrsti proizvodov (zaščitna sredstva v gradbeništvu), kot sta opredeljeni v Prilogi V k navedeni uredbi, ki ustrezata 7. in 10. vrsti proizvodov, kot sta opredeljeni v Prilogi V k Uredbi (EU) št. 528/2012.
Denmark was designated as rapporteur Member State and submitted the competent authority reports, together with recommendations, to the Commission on 16 April 2012 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Danska, ki je bila imenovana za državo članico poročevalko, je 16. aprila 2012 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročili pristojnega organa in priporočili.
It appears from those reports that biocidal products used for product-types 7 and 10 and containing tebuconazole may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Iz navedenih poročil je razvidno, da je za biocidne proizvode, ki se uporabljajo kot proizvodi v 7. in 10. vrsti proizvodov in vsebujejo tebukonazol, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
It also appears from the reports that the characteristics of tebuconazole render it very persistent (vP) and toxic (T) in accordance with the criteria laid down in Annex XIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council [4].
Iz poročil je razvidno tudi, da je tebukonazol zaradi svojih značilnosti v skladu z merili iz Priloge XIII k Uredbi (ES) št. 1907/2006 Evropskega Parlamenta in Sveta [4] zelo obstojen (vP) in strupen (T).
However, for the purpose of authorising products in accordance with Article 23 of Regulation (EU) No 528/2012, tebuconazole shall be considered as a candidate for substitution pursuant to Article 10(1)(d) of that Regulation.
Vendar bi bilo treba za namene odobritve proizvodov v skladu s členom 23 Uredbe (EU) št. 528/2012 tebukonazol obravnavati kot kandidata za nadomestitev v skladu s členom 10(1)(d) navedene uredbe.
It is therefore appropriate to approve tebuconazole for use in biocidal products for product-types 7 and 10.
Zato je primerno odobriti tebukonazol za uporabo v biocidnih proizvodih 7. in 10. vrste proizvodov.
Tebuconazole shall be approved as an active substance for use in biocidal products for product-types 7 and 10, subject to the specifications and conditions set out in the Annex.
Tebukonazol se odobri kot aktivna snov za uporabo v biocidnih proizvodih 7. in 10. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
Tebuconazole is considered a candidate for substitution in accordance with Article 10(1)(d) of Regulation (EU) No 528/2012.
Tebukonazol se šteje kot kandidat za nadomestitev v skladu s členom 10(1)(d) Uredbe (EU) št. 528/2012.
For industrial users, safe operational procedures and appropriate organisational measures shall be established.
Za industrijske uporabnike se vzpostavijo postopki varnega ravnanja in primerni organizacijski ukrepi.
Where exposure cannot be reduced to an acceptable level by other means, products shall be used with appropriate personal protective equipment.
Če izpostavljenosti ni mogoče zmanjšati na sprejemljivo raven z drugimi načini, se proizvodi uporabljajo z ustrezno osebno zaščitno opremo;
For industrial or professional users, safe operational procedures and appropriate organisational measures shall be established.
za industrijske ali poklicne uporabnike se vzpostavijo postopki varnega ravnanja in primerni organizacijski ukrepi.
In the view of the risk for the soil compartment, tebuconazole shall not be used in a sealant that will be used to seal vertical joints outside residential facades (e.g. between two houses), unless it can be demonstrated in the application for product authorisation that risks can be reduced to an acceptable level by other means.
glede na tveganje za tla se tebukonazol ne uporablja v tesnilnih masah, ki se uporabljajo za zatesnitev vertikalnih sklepov zunaj stanovanjskih fasad (npr. med dvema hišama), razen če ni v vlogi za izdajo dovoljenja dokazano, da se tveganja lahko zmanjšajo na sprejemljivo raven na druge načine.
Commission Implementing Regulation (EU) No 1039/2013
Izvedbena uredba Komisije (EU) št. 1039/2013
modifying the approval of nonanoic acid as an existing active substance for use in biocidal products for product-type 2
o spremembi odobritve nonanojske kisline kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 2. vrste proizvodov
Nonanoic acid has been included into Annex I to Directive 98/8/EC for use in product-type 2 through Commission Directive 2012/41/EU [4], and is therefore considered as approved for that product-type by virtue of Article 86 of Regulation (EU) No 528/2012.
Nonanojska kislina je bila z Direktivo Komisije 2012/41/EU [4] vključena v Prilogo I k Direktivi 98/8/ES za uporabo v 2. vrsti proizvodov in se zato šteje kot odobrena za navedeno vrsto proizvodov v skladu s členom 86 Uredbe (EU) št. 528/2012.
Furthermore, nonanoic acid has been evaluated in accordance with Article 11(2) of Directive 98/8/EC for use in product-type 10, masonry preservatives, as defined in Annex V to that Directive.
Poleg tega je bila v skladu s členom 11(2) Direktive 98/8/ES opravljena presoja nonanojske kisline za uporabo v 10. vrsti proizvodov (zaščitna sredstva v gradbeništvu), kot je opredeljena v Prilogi V k navedeni direktivi.
The evaluation covered use as an algaecide for the curative treatment of construction materials.
Presoja je obravnavala uporabo kot algicid za sanacijo gradbenega materiala.
That specific use is now covered by product-type 2 as defined in Annex V to Regulation (EU) No 528/2012.
Ta posebna uporaba je zdaj zajeta v 2. skupini proizvodov, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
Austria was designated as Rapporteur Member State and submitted the competent authority report, together with a recommendation, to the Commission on 3 April 2012 in accordance with Article 14(4) and (6) of Regulation (EC) No 1451/2007.
Avstrija, ki je bila imenovana za državo članico poročevalko, je 3. aprila 2012 v skladu s členom 14(4) in (6) Uredbe (ES) št. 1451/2007 Komisiji poslala poročilo pristojnega organa in priporočilo.
It appears from that report that biocidal products used as an algaecide for the curative treatment of construction materials and containing nonanoic acid may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC.
Iz navedenega poročila je razvidno, da je za biocidne proizvode, ki se uporabljajo kot algicidi za sanacijo gradbenega materiala in vsebujejo nonanojsko kislino, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES.
The existing approval of nonanoic acid for product-type 2 does not cover the conditions resulting from the evaluation of products used as an algaecide for the curative treatment of construction materials.
Obstoječa odobritev nonanojske kisline za uporabo v 2. vrsti proizvodov ne vključuje pogojev, ki so posledica presoje proizvodov, ki se uporabljajo kot algicidi za sanacijo gradbenega materiala.
It is therefore appropriate to complement that existing approval with those conditions.
Zato je primerno, da se obstoječa odobritev dopolni z navedenimi pogoji.
For the purpose of allowing all interested parties to prepare themselves to meet the new requirements following from the recent redefinition of biocidal product-types, it is furthermore appropriate to modify the date of approval originally provided for by Directive 2012/41/EU.
Da bi se lahko vse zainteresirane strani pripravile na izpolnjevanje novih pogojev na podlagi nedavne spremembe opredelitev vrst biocidnih proizvodov, je zlasti primerno tudi spremeniti datum odobritve, prvotno določen v Direktivi 2012/41/EU.
Nonanoic acid shall be approved as an active substance for use in biocidal products for product-type 2, subject to the specifications, the new conditions and the new date of approval set out in the Annex.
Nonanojska kislina se odobri kot aktivna snov za uporabo v biocidnih proizvodih 2. vrste proizvodov, pri čemer se upoštevajo specifikacije, novi pogoji in nov datum odobritve iz Priloge.